Maria Tanaka

Comorbidities predict worse prognosis in patients with primary myelofibrosis

Kate J. Newberry, Kiran Naqvi, Khanh Nguyen et al. · Cancer · 2014 · 34 citations · Full text

Medicine, Clinical Sciences, Hematology +17

Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

Naveen Pemmaraju, Maria Tanaka, Farhad Ravandi et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 32 citations · Full text

Medicine, Hematology, Oncology +13

Final Report of a Phase II Study of 5-Azacitidine and Vorinostat in Patients (pts) with Newly Diagnosed Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML) Not Eligible for Clinical Trials Because Poor Performance and Presence of Other Comorbidities

Guillermo Garcia‐Manero, Elihu H. Estey, Elias Jabbour et al. · Blood · 2011 · 26 citations

Medicine, Oncology, Pharmacology +15

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case–control study

Elias Jabbour, Michael S. Mathisen, Guillermo Garcia‐Manero et al. · American Journal of Hematology · 2012 · 14 citations · Full text

Medicine, Hematology, Hematologic Oncology +14

Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities

Christopher B. Benton, Maria Tanaka, Catherine Wilson et al. · Leukemia Research · 2015 · 12 citations · Full text

Medicine, Hematology, Pathology +11